v3.22.4
Stock-Based Compensation (Tables)
 12 Months Ended
Jan. 29, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense, Net of Amounts Capitalized as Inventory
Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows:
 Year Ended
January 29,
2023		January 30,
2022		January 31,
2021
 (In millions)
Cost of revenue$138 $141 $88 
Research and development1,892 1,298 860 
Sales, general and administrative680 565 449 
Total$2,710 $2,004 $1,397 
Schedule of Equity Awards
The following is a summary of equity awards granted under our equity incentive plans:
Year Ended
January 29,
2023		January 30,
2022		January 31,
2021
(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
Awards granted25 18 36 
Estimated total grant-date fair value$4,505 $3,492 $2,764 
Weighted average grant-date fair value per share$183.72 $190.69 $76.81 
ESPP
Shares purchased3 5 4 
Weighted average price per share$122.54 $56.36 $34.80 
Weighted average grant-date fair value per share$51.87 $23.24 $16.91 
Schedule of ESPP Valuation Assumptions
The fair value of shares issued under our ESPP have been estimated with the following assumptions:
 Year Ended
 January 29,
2023		January 30,
2022		January 31,
2021
(Using the Black-Scholes model)
ESPP
Weighted average expected life (in years)
0.1-2.0
0.1-2.0
0.1-2.0
Risk-free interest rate
—%-4.6%
—%-0.5%
0.1%-1.6%
Volatility
43%-72%
20%-58%
26%-89%
Dividend yield
0.1%
0.1%
0.1%-0.3%
Schedule of Equity Award Transactions
The following is a summary of our equity award transactions under our equity incentive plans: 
RSUs, PSUs and Market-based PSUs Outstanding
 Number of SharesWeighted Average Grant-Date Fair Value
(In millions, except per share data)
Balances, January 30, 202246 $114.19 
Granted25 $183.72 
Vested restricted stock(24)$100.06 
Canceled and forfeited(2)$141.17 
Balances, January 29, 202345 $158.45 
Vested and expected to vest after January 29, 202345 $158.35